Risk factors for peri-parturient farmer diagnosed mastitis in New Zealand dairy herds: Findings from a retrospective cohort study

Preventive Veterinary Medicine

Volumn 127, Issue , 2016, Pages 70-76

  Bates, A J ^a   Dohoo, I ^b  

^a Centre for Dairy Excellence   (New Zealand)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Dry cow therapy; Dry period; Mastitis; Pastoral; Risk factor

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALONIUM; CEPHALOSPORIN DERIVATIVE;

AGRICULTURAL WORKER; ANIMAL; BOVINE; COHORT ANALYSIS; FEMALE; LACTATION; MASTITIS, BOVINE; MICROBIOLOGY; NEW ZEALAND; PERINATAL PERIOD; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; COHORT STUDIES; FARMERS; FEMALE; LACTATION; MASTITIS, BOVINE; NEW ZEALAND; PERIPARTUM PERIOD; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84962030053     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2016.03.009     Document Type: Article

References (31)

1. Barkema H.W., Van der Ploeg J.D., Schukken Y.H., Lam T.J., Benedictus G., Brand A. Management style and its association with bulk milk somatic cell count and incidence rate of clinical mastitis. J. Dairy Sci. 1999, 82:1655-1663.
2. Bartlett P.C., Miller G.Y., Anderson C.R., Kirk J.H. Milk production and somatic cell count in Michigan dairy herds. J. Dairy Sci. 1990, 73:2794-2800.
3. Bates A., Chambers G., Laven R. Comparison of cephalonium alone and in combination with an internal teat sealant for dry cow therapy in seasonally calving dairy cows. N. Z. Vet. J. 2015, 0169:1-16. 10.1080/00480169.2015.1093970.
4. Berry E.A., Hillerton J.E. Effect of an intramammary teat seal and dry cow antibiotic in relation to dry period length on postpartum mastitis. J. Dairy Sci. 2007, 90:760-765. 10.3168/jds.S0022-0302(07)71560-6.
5. Bradley A.J., Breen J.E., Payne B., Williams P., Green M.J. The use of a cephalonium containing dry cow therapy and an internal teat sealant, both alone and in combination. J. Dairy Sci. 2010, 93:1566-1577. 10.3168/jds.2009-2725.
6. Bryan M.A., Heuer C., Emslie F.R. The comparative efficacy of two long-acting dry-cow cephalonium products in curing and preventing intramammary infections products in curing and preventing intramammary infections. N. Z. Vet. J. 2011, 59:166-173. 10.1080/00480169.2011.579245.
7. Collier R.J., Annen-Dawson E.L., Pezeshki A. Effects of continuous lactation and short dry periods on mammary function and animal health. Animal 2012, 6:403-414. 10.1017/S1751731111002461.
8. Eberhart R.J. Management of dry cows to reduce mastitis. J. Dairy Sci. 1986, 69:1721-1732.
9. Gasqui P., Barnouin J. Statistical modelling for clinical mastitis in the dairy cow: problems and solutions. J. Vet. Res. 2003, 34:493-505.
10. Giolo S.R., Krieger J.E., Mansur A.J., Pereira A.C. Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality. PLoS One 2012, 7:1-9. 10.1371/journal.pone.0037392.
11. Godden S., Rapnicki P., Stewart S., Fetrow J., Johnson a, Bey R., Farnsworth R. Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J. Dairy Sci. 2003, 86:3899-3911. 10.3168/jds.S0022-0302(03)73998-8.
12. Holmes C., Brookes I., Garrick G., Mackenzie D., Parkinson T., Wilson G. Feeding the Herd: Management of Feed Demand in the Pastoral Dairy System, In: Milk Production from Pasture 2002, 91-118. Massey University, Palmerston North, New Zealand.
13. Hosmer D., Royston P. Using Aalen's linear hazards model to investigate time-varying effects in the proportional hazards regression model. Stata J. 2002, 2:331-350.
14. Lago A., Godden S., Bey R., Ruegg P., Leslie K. The selective treatment of clinical mastitis based on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes. J. Dairy Sci. 2011, 94:4441-4456. 10.3168/jds.2010-4046.
15. Laven R.A., Lawrence K.E. Efficacy of blanket treatment of cows and heifers with an internal teat sealant in reducing the risk of mastitis in dairy cattle calving on pasture. N. Z. Vet. J. 2008, 56:171-175. 10.1080/00480169.2008.36830.
16. Laven R.A., Balcomb C.C., Tulley W.T., Lawrence K.E. Effect of dry period length on the effect of an intramammary teat sealant on the risk of mastitis in cattle treated with antibiotics at drying off. N. Z. Vet. J. 2014, 62:214-220. 10.1080/00480169.2013.879689.
17. Madouasse A., Browne W., Huxley J., Toni F., Bradley A., Green M. Risk factors for a high somatic cell count at the first milk recording in a large sample of UK dairy herds. J. Dairy Sci. 2012, 1873-1884. 10.3168/jds.2011-4801.
18. McDougall S., Arthur D., Bryan M.A., Vermunt J., Weir A. Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics. N. Z. Vet. J. 2007, 55:161-170.
19. McDougall S. Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows. N. Z. Vet. J. 1998, 46:226-232. 10.1080/00480169.1998.36094.
20. McDougall S. Management factors associated with the incidence of clinical mastitis over the non-lactation period and bulk tank somatic cell count during the subsequent lactation. N. Z. Vet. J. 2003, 51:63-72. 10.1080/00480169.2003.36342.
21. McDougall S. A randomised, non-inferiority trial of a new cephalonium dry-cow therapy. N. Z. Vet. J. 2010, 58:45-58. 10.1080/00480169.2010.65060.
22. McKeague I., Sasienei P. A partly parametric additive risk model. Biometrika 1994, 81:501-514. 10.1093/biomet/81.3.501.
23. Newton H., Green Martin M.J., Benchaoui H., Cracknel V., Rowan T., Bradly A.J. Comparison of the efficacy of cloxacillin alone and cloxacillin combined with an internal teat sealant for dry-cow therapy. Vet. Rec. 2008, 162:678-684.
24. Olde Riekerink R.G.M., Barkema H.W., Kelton D.F., Scholl D.T. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 2008, 91:1366-1377. 10.3168/jds.2007-0757.
25. Petrovski K., Heuer C., Parkinson T., Williamson N.B. The incidence and aetiology of clinical bovine mastitis on 14 farms in Northland, New Zealand. N. Z. Vet. J. 2009, 57:109-115. 10.1080/00480169.2009.36887.
26. Rabiee A., Lean I. The effect of internal teat sealant products (Teatseal and Orbeseal) on intramammary infection, clinical mastitis, and somatic cell counts in lactating dairy cows: a meta-analysis. J. Dairy Sci. 2013, 96:69135-69231. 10.3168/jds.2013-6544.
27. Robert A., Seegers H., Bareille N. Incidence of intramammary infections during the dry period without or with antibiotic treatment in dairy cows-a quantitative analysis of published data. Vet. Res. 2006, 37:25-48.
28. Roche J., Friggens N., Kay J., Fisher M., Stafford K., Berry D. Invited review: body condition score and its association with dairy cow productivity, health, and welfare. J. Dairy Sci. 2009, 92:5769-5801. 10.3168/jds.2009-2431.
29. Runciman D.J., Malmo J., Deighton M. The use of an internal teat sealant in combination with cloxacillin dry cow therapy for the prevention of clinical and subclinical mastitis in seasonal calving dairy cows. J. Dairy Sci. 2010, 93:4582-4591. 10.3168/jds.2009-2956.
30. Woolford M., Williamson J., Day A., Copeman P. The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation. N. Z. Vet. J. 1999, 46:12-18. 10.1080/00480169.1998.36044.
31. Xu Z., Burton L. Reproductive Performance of Dairy Cows in New Zealand. Research and Development Group 2003, Livestock Improvement Corporation.